ArticleBiochemistry and biophysics reports2025
Smooth muscle cell (SMC)-Specific SNRK deletion in mouse causes congenital short bowel syndrome and premature death.
Article in Biochemistry and biophysics reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advances in research on congenital and hereditary intestinal diseases: From molecular mechanisms to precision medicine.Intractable & rare diseases research · 2025Review
Corrections and comments
- Erratum issued
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Congenital short bowel syndrome (CSBS), a rare gastrointestinal disorder characterized by reduced small intestine length, remains etiologically undefined. This study investigates the role of sucrose nonfermenting 1-related kinase (SNRK) in intestinal smooth muscle cells (SMCs) during development and in adult homeostasis using two mouse models: a congenital SMC-specific Snrk knockout (SNRK-SMKO) and an inducible adult knockout. SNRK-SMKO mice died prematurely and exhibited shortened intestines, dilated lumens, and a thinner circular muscle layer without evidence of increased apoptosis. In contrast, adult-onset Snrk deletion had no apparent effect. Western blot analysis revealed elevated SMC contractile proteins in neonatal (postnatal day 3.5) SNRK-SMKO colons, which declined during maturation. 5-Ethynyl-2'-deoxyuridine (EdU) incorporation assays showed persistently reduced SMC proliferation in the circular muscle layer of both small intestine and colon across postnatal developmental stages. These results establish SNRK as a critical regulator of intestinal SMC proliferation during development, with its deficiency underlies CSBS-like pathology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.